002010:SZSETransfar Zhilian Co., Ltd. Analysis
Data as of 2026-06-18 - not real-time
CN¥4.89
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Transfar Zhilian is trading at CNY 4.89, well below its 20‑day (CNY 5.14) and 50‑day (CNY 5.49) moving averages, indicating a bearish price trend. However, the RSI of 33.9 suggests the stock is oversold, and the MACD line sits just above its signal line, producing a bullish histogram signal that could spark a short‑term bounce.
Fundamentally, the company appears cheap with a price‑to‑book of 0.74 and an upside potential of roughly 34 % to the consensus target of CNY 6.58. Yet earnings are under pressure – revenue fell 34 % YoY, margins are thin (gross 16 %, net 2.9 %), and debt‑to‑equity sits at a high 71 %. The dividend yield of 3 % and a payout ratio of 63 % provide income appeal, but the heavy debt load and weak cash conversion add caution. Overall, the stock sits at a valuation discount with modest income upside, but the combination of bearish technical positioning, volatile price swings (30‑day volatility ~25 %) and sector cyclicality tempers enthusiasm.
Fundamentally, the company appears cheap with a price‑to‑book of 0.74 and an upside potential of roughly 34 % to the consensus target of CNY 6.58. Yet earnings are under pressure – revenue fell 34 % YoY, margins are thin (gross 16 %, net 2.9 %), and debt‑to‑equity sits at a high 71 %. The dividend yield of 3 % and a payout ratio of 63 % provide income appeal, but the heavy debt load and weak cash conversion add caution. Overall, the stock sits at a valuation discount with modest income upside, but the combination of bearish technical positioning, volatile price swings (30‑day volatility ~25 %) and sector cyclicality tempers enthusiasm.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Oversold RSI indicating near‑term price rebound
- Bullish MACD crossover despite bearish trend
- Attractive 3 % dividend yield with reasonable payout
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation discount (P/B 0.74) offering upside to target
- Persistent revenue decline and high debt weight risk
- Stable dividend income offsetting earnings weakness
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Fundamental value appeal in a cyclical specialty‑chemicals sector
- Long‑term debt burden and modest ROE limiting growth
- Potential for dividend sustainability if cash flow improves
Key Metrics & Analysis
Financial Health
Revenue Growth-34.40%
Profit Margin2.86%
P/E Ratio20.4
ROE3.71%
ROA1.59%
Debt/Equity71.03
P/B Ratio0.7
Op. Cash FlowCN¥1.3B
Free Cash FlowCN¥707.6M
Technical Analysis
TrendBearish
RSI34.0
SupportCN¥4.76
ResistanceCN¥5.61
MA 20CN¥5.14
MA 50CN¥5.49
MA 200CN¥6.03
MACDBullish
VolumeDecreasing
Fear & Greed Index91.14
Valuation
Target PriceCN¥6.58
Upside/Downside34.56%
GradeUndervalued
TypeValue
Dividend Yield3.00%
Risk Assessment
Beta0.44
Volatility25.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.